Health Care/Hospital

ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study

MINNEAPOLIS, Nov. 30, 2023 /PRNewswire/ -- ShiraTronics, Inc., a pioneering medical device company, today announced the initiation of its groundbreaking RELIEV-CM pilot study inAustralia, marking the world's first seven patients' successful completion of trial phase procedures for their Chronic M...

2023-11-30 07:12 1139

Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS

MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candid...

2023-11-30 04:15 1382

Unither Pharmaceuticals celebrates 30 years of innovation and expertise

PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. T...

2023-11-30 02:42 1688

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq.­ * No dose limiting toxicit...

2023-11-29 21:58 1232

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its Dry Eye Disease (DED) therape...

2023-11-29 21:00 2865

Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom ofBahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment ...

2023-11-29 17:52 1724

Zhang Yu with Tencent Health: AI-Driven Customer Interaction Solution NGES Effectively Supports Pharmaceutical Enterprises' Smart Operations

SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- In recent years, the Chinese pharmaceutical industry has been undergoing significant changes in its operational methods, driven by improvements in national regulations and changes in user behaviors and attitudes. Traditional operational approaches and mark...

2023-11-29 17:49 1696

Ping An Health Wins Good Design Award for Its Innovative Design

SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- Ping An Health was recently honored with Japan's Good Design Award, commonly known as the "The oriental Oscar Award of Design", for its outstanding innovation design and user-friendly design.

2023-11-29 17:31 1950

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases

SUZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Earlier this month, magAssist Co.,Ltd. ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices inChina, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS)...

2023-11-29 14:06 1101

GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC

–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific – – Since 2018, The Gilead Asia Pacific Rainbow Grant Has Awarded Close To US$6 Million To 144 Community-Based Projects In The Region, Supporting 130 00...

2023-11-29 11:00 1597

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

BANGKOK, Nov. 29, 2023 /PRNewswire/ -- Chula  Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient's lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, ...

2023-11-29 10:00 1281

VISTA Eye Specialist Unveils Innovative Solution for Reading Problems

PETALING JAYA, Malaysia, Nov. 29, 2023 /PRNewswire/ -- VISTA Eye Specialist (VISTA) proudly introduces the groundbreaking EVO Viva Implantable Collamer Lens (Viva) to address the dual challenge of short-sightedness and reading problems (presbyopia) among patients aged above 40. This cutting-edge ...

2023-11-29 08:00 1375

Kailo Medical Presents: KailoFlow - Elevating the Generative Reporting Experience to the Web

CHICAGO, Nov. 29, 2023 /PRNewswire/ -- Kailo Medical, a recognized leader in medical software and services, proudly announces the launch ofKailoFlow, the web-based evolution of the premier structured reporting platform,SonoReview. Marrying progress, innovation, and accessibility, KailoFlow is the...

2023-11-29 07:11 948

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

* Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics® technology. * PRISM BioLab receives upfront payments and up to $660 million in total milestones, plus royalties on net sales. TOKYO, Nov. 2...

2023-11-29 04:01 1206

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

SINGAPORE, Nov. 28, 2023 /PRNewswire/ -- Wonder Technologies PTE. LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based inSingapore, has reached a breakthrough in its acoustics-based AI for depression screening. The AI model, which identifies depression t...

2023-11-29 00:00 1560

uLab® enables direct-to-patient shipments for uSmile™ Retainers

MEMPHIS, Tenn., Nov. 29, 2023 /PRNewswire/ -- uLab Systems™, an innovation leader in the clear aligner market and maker of the uSmile aligner product line, the uDesign® treatment planning software and the uAssist™ concierge service that together create the Smart Outcomes™ for a Smart Office™ plat...

2023-11-28 23:15 1279

Safeena Husain, Founder of Educate Girls, honoured with the WISE Prize for Education

The first Indian woman to win the WISE Prize for Education for her contribution to girls' education in ruralIndia MUMBAI, India, Nov. 28, 2023 /PRNewswire/ -- Safeena Husain, Founder, Educate Girls, hasbeen awarded the prestigious WISE Prize for Education at the WISE 11 Summit (World Innovation ...

2023-11-28 23:04 1415

Rhino Rescue Expands Horizons at Medica 2023, Exploring New Opportunities in the European Market

DÜSSELDORF, Germany, Nov. 28, 2023 /PRNewswire/ -- Rhino Rescue made a strong appearance at Medica inGermany, showcasing the comprehensive range of its latest technologies and products. During the event, more than 20 companies expressed their intention to partner with Rhino Rescue, thereby expand...

2023-11-28 23:00 1147

MAIRE' S NEXTCHEM EXPANDS ITS TECHNOLOGY PORTFOLIO WITH THE DEVELOPMENT AND SUPPLY OF CLARIANT' NEXT GENERATION CATALYST

MILAN, Nov. 28, 2023 /PRNewswire/ -- MAIRE S.p.A. announces that Conser S.p.A., part of MAIRE Sustainable Technology Solutions business unit led by NEXTCHEM, has reached an agreement withClariant for the development and supply of Clariant'snext generation maleic anhydride catalysts. This agreeme...

2023-11-28 22:00 1338

Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award

BOSTON, Nov. 28, 2023 /PRNewswire/ -- Dr. Liu Jian, President of the Drug Discovery Division at Medicilon, has been awarded the Thomas Alva Edison Patent Award for 2023 from the New Jersey Research and Development Committee. This recognition stems from his innovative patent on the PCSK9 inhibitor...

2023-11-28 21:30 1026
1 ... 59606162636465 ... 807